ssstyles@ I also myself only understood this fully yesterday (after Q1 conference).
Settlement with Hikma and Reddy is not an option (wouldn't mean anything) - because of the '6 Patens that judge DU overruled' - the field is' as of right now' - open to any generics in the world 'to copy' and sell 'Vascepa Copy' (generich) in the US.
Only chance to Reverse That is to win the Appeal - why reality is that Amarin has no choice - but to 'go all in' (which is what they do) - In Winning the Appeal.